Oncology and Hematology - Prova Education

Episodes 1-16 of 28

- Thomas F. Patterson, MD, FACP, FIDSA
  Peer
- George Thompson III, MD, FIDSA
  Peer
0
CME/CE
Treatment Options for Invasive Fungal Infections: Why They Don't Always Work
Treatment Options for Invasive Fungal Infections: Why They Don't Always Work
0.25 credits
Treatment Options for Invasive Fungal Infections: Why They Don't Always Work
0.25 credits
- Andrew H. Lipsky, MD
  Peer
- Jacob D. Soumerai, MD
  Peer
- Catherine C. Coombs, MD
  Peer
0
CME/CE Broadcast Replay
CME/CE Broadcast Replay
Individualized Approaches in CLL/SLL: Meeting the Needs of Your Patients Now and Preparing for the Future
Individualized Approaches in CLL/SLL: Meeting the Needs of Your Patients Now and Preparing for the Future
1.00 credit
Individualized Approaches in CLL/SLL: Meeting the Needs of Your Patients Now an…
1.00 credit
- Peter G. Pappas, MD, FACP
  Peer
- Thomas F. Patterson, MD, FACP, FIDSA
  Peer
1
CME/CE
Invasive Fungal Infections: More Common Than You Think
Invasive Fungal Infections: More Common Than You Think
0.25 credits
Invasive Fungal Infections: More Common Than You Think
0.25 credits
- Saad Z. Usmani, MD, MBA, FACP
  Peer
- Sikander Ailawadhi, MD
  Peer
- Amrita Krishnan, MD
  Peer
1
CME/CE Broadcast Replay
CME/CE Broadcast Replay
BCMA Who and When: Immunotherapies in Patients with RRMM
BCMA Who and When: Immunotherapies in Patients with RRMM
1.00 credit
BCMA Who and When: Immunotherapies in Patients with RRMM
1.00 credit
- Floor J. Backes, MD
  Peer
1
CME/CE
Improving Outcomes in Patients with Ovarian Cancer: Multidisciplinary Patient-Centered Care
Improving Outcomes in Patients with Ovarian Cancer: Multidisciplinary Patient-Centered Care
0.25 credits
Improving Outcomes in Patients with Ovarian Cancer: Multidisciplinary Patient-C…
0.25 credits
- Lindsey Roeker, MD
  Peer
0
CME/CE
BTKIs for the treatment of CLL/SLL: The Patient Journey
BTKIs for the treatment of CLL/SLL: The Patient Journey
0.25 credits
BTKIs for the treatment of CLL/SLL: The Patient Journey
0.25 credits
- Patrick Forde, M.B.B.Ch.
  Peer
- Jesús García-Foncillas, MD, PHD
  Peer
0
CME/CE
Why ICIs Have Revolutionized Cancer Care
Why ICIs Have Revolutionized Cancer Care
0.25 credits
Why ICIs Have Revolutionized Cancer Care
0.25 credits
- Lindsey Roeker, MD
  Peer
1
CME/CE
Treatment of CLL/SLL with BTKis: Whole Patient Approaches
Treatment of CLL/SLL with BTKis: Whole Patient Approaches
0.25 credits
Treatment of CLL/SLL with BTKis: Whole Patient Approaches
0.25 credits
- Rami Komrokji, MD
  Peer
0
CME/CE
ESA Failure in Low-Risk MDS: ESA Failure Criteria and Emerging Options to Promote Transfusion Independence
ESA Failure in Low-Risk MDS: ESA Failure Criteria and Emerging Options to Promote Transfusion Independence
0.25 credits
ESA Failure in Low-Risk MDS: ESA Failure Criteria and Emerging Options to Promo…
0.25 credits
- Cem Akin, MD, PhD
  Peer
- Deepti Radia, MD
  Peer
4
CME/CE
Indolent Systemic Mastocytosis (ISM): Treatment Options for ISM
Indolent Systemic Mastocytosis (ISM): Treatment Options for ISM
0.25 credits
Indolent Systemic Mastocytosis (ISM): Treatment Options for ISM
0.25 credits
- Guillermo Garcia-Manero, MD
  Peer
- Rami Komrokji, MD
  Peer
1
CME/CE
A Primer on the Management of MDS-Associated Anemia
A Primer on the Management of MDS-Associated Anemia
0.25 credits
A Primer on the Management of MDS-Associated Anemia
0.25 credits
- Cem Akin, MD, PhD
  Peer
- Jason Gotlib, MD, MS
  Peer
4
CME/CE
Indolent Systemic Mastocytosis (ISM): Tools to Diagnose ISM
Indolent Systemic Mastocytosis (ISM): Tools to Diagnose ISM
0.25 credits
Indolent Systemic Mastocytosis (ISM): Tools to Diagnose ISM
0.25 credits
- Mark Socinski, MD
  Peer
- Jennifer Marie Suga, MD, MPH
  Peer
3
CME/CE
Personalizing NSCLC: The Optimal Applicability of NGS and Liquid Biopsy
Personalizing NSCLC: The Optimal Applicability of NGS and Liquid Biopsy
0.25 credits
Personalizing NSCLC: The Optimal Applicability of NGS and Liquid Biopsy
0.25 credits
- Shaji K. Kumar, MD
  Peer
- María-Victoria Mateos, MD, PhD
  Peer
1
CME/CE
Multiple Myeloma: Updates from ASCO 2022
Multiple Myeloma: Updates from ASCO 2022
0.25 credits
Multiple Myeloma: Updates from ASCO 2022
0.25 credits
- Susan O’Brien, MD
  Peer
- Timothy Call, MD
  Peer
1
CME/CE
State of the Union: A Targeted Approach in First-Line Treatment of CLL/SLL
State of the Union: A Targeted Approach in First-Line Treatment of CLL/SLL
0.25 credits
State of the Union: A Targeted Approach in First-Line Treatment of CLL/SLL
0.25 credits
- Cesar Rodriquez Valdes, MD
  Peer
- Amrita Krishnan, MD
  Peer
4
CME/CE
Keeping Pace in Hematologic Malignancies: Novel Targets for Multiple Myeloma
Keeping Pace in Hematologic Malignancies: Novel Targets for Multiple Myeloma
0.25 credits
Keeping Pace in Hematologic Malignancies: Novel Targets for Multiple Myeloma
0.25 credits

Prev
1
2
Next

1/2